|
EP0804561B1
(en)
|
1993-02-12 |
2009-12-30 |
The Board Of Trustees Of The Leland Stanford Junior University |
Regulated transcription of targeted genes and other biological events
|
|
AU719001B2
(en)
|
1994-12-29 |
2000-05-04 |
Massachusetts Institute Of Technology |
Chimeric DNA-binding proteins
|
|
WO1996041865A1
(en)
|
1995-06-07 |
1996-12-27 |
Ariad Gene Therapeutics, Inc. |
Rapamcycin-based regulation of biological events
|
|
US6884879B1
(en)
|
1997-04-07 |
2005-04-26 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
JP2003524368A
(ja)
|
1997-08-26 |
2003-08-19 |
アリアド ジーン セラピューティクス インコーポレイテッド |
ニ量化ドメイン、三量化ドメインまたは四量化ドメインおよび補足的非相同転写活性化ドメイン、転写抑制ドメイン、ｄｎａ結合ドメインまたはリガンド結合ドメインを含む融合蛋白
|
|
JP2001514007A
(ja)
|
1997-08-27 |
2001-09-11 |
アリアド ジーン セラピューティクス インコーポレイテッド |
キメラ転写アクチベーター、ならびにそれに関連する組成物および使用
|
|
JP2002508971A
(ja)
|
1998-01-15 |
2002-03-26 |
アリアド・ジーン・セラピューティクス・インコーポレーテッド |
多量体キメラ蛋白質を使用する生物学的イベントの調節
|
|
JP2002503667A
(ja)
|
1998-02-13 |
2002-02-05 |
プレジデント・アンド・フェローズ・オブ・ハーバード・カレッジ |
新規な二量体化剤、その製造および使用
|
|
CA2379166C
(en)
|
1999-08-09 |
2013-03-26 |
Targeted Genetics Corporation |
Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms instrastrand base pairs
|
|
US7067526B1
(en)
|
1999-08-24 |
2006-06-27 |
Ariad Gene Therapeutics, Inc. |
28-epirapalogs
|
|
BR0014945A
(pt)
|
1999-10-21 |
2004-08-31 |
Monsanto Co |
Modificação pós-traducional de proteìnas recombinantes produzidas em plantas
|
|
GB2362884A
(en)
|
2000-05-30 |
2001-12-05 |
Isis Innovation |
Extended duration of airway gene therapy
|
|
CN1461342A
(zh)
|
2000-07-26 |
2003-12-10 |
路德维格癌症研究所 |
糖基化vegf－b和增加可溶性vegf－b量的方法
|
|
MX359371B
(es)
|
2001-11-13 |
2018-09-25 |
Univ Pennsylvania |
Un metodo para detectar y/o identificar secuencias del virus adeno-asociado y aislamiento de secuencias novedosas identificadas de ese modo.
|
|
PT1453547T
(pt)
|
2001-12-17 |
2016-12-28 |
Univ Pennsylvania |
Sequências do vírus adeno-associado (aav) do serotipo 8, vetores contendo as mesmas, e utilizações destas
|
|
WO2003068801A2
(en)
|
2002-02-11 |
2003-08-21 |
Genentech, Inc. |
Antibody variants with faster antigen association rates
|
|
US20040208847A1
(en)
|
2003-03-28 |
2004-10-21 |
Fabienne Rolling |
Method and vectors for selectively transducing retinal pigment epithelium cells
|
|
EP2345731B1
(en)
|
2003-09-30 |
2015-10-21 |
The Trustees of the University of Pennsylvania |
Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof
|
|
ES2525067T3
(es)
|
2005-04-07 |
2014-12-17 |
The Trustees Of The University Of Pennsylvania |
Método de incremento de la función de un vector de AAV
|
|
JP4495210B2
(ja)
|
2005-06-09 |
2010-06-30 |
パナソニック株式会社 |
振幅誤差補償装置及び直交度誤差補償装置
|
|
ES2533266T5
(es)
|
2007-10-30 |
2018-04-18 |
Genentech, Inc. |
Purificación de anticuerpos mediante cromatografía de intercambio catiónico
|
|
TWI468417B
(zh)
|
2007-11-30 |
2015-01-11 |
Genentech Inc |
抗－ｖｅｇｆ抗體
|
|
KR101010352B1
(ko)
|
2008-05-30 |
2011-01-25 |
삼성중공업 주식회사 |
전력 제어 장치 및 방법
|
|
CA2742969A1
(en)
|
2008-11-07 |
2010-05-14 |
Fabrus Llc |
Anti-dll4 antibodies and uses thereof
|
|
US8734809B2
(en)
|
2009-05-28 |
2014-05-27 |
University Of Massachusetts |
AAV's and uses thereof
|
|
EP2443150B1
(en)
*
|
2009-06-17 |
2015-01-21 |
AbbVie Biotherapeutics Inc. |
Anti-vegf antibodies and their uses
|
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
US8628966B2
(en)
|
2010-04-30 |
2014-01-14 |
City Of Hope |
CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer
|
|
US8663624B2
(en)
|
2010-10-06 |
2014-03-04 |
The Regents Of The University Of California |
Adeno-associated virus virions with variant capsid and methods of use thereof
|
|
WO2012057363A1
(ja)
|
2010-10-27 |
2012-05-03 |
学校法人自治医科大学 |
神経系細胞への遺伝子導入のためのアデノ随伴ウイルスビリオン
|
|
WO2012109570A1
(en)
|
2011-02-10 |
2012-08-16 |
The University Of North Carolina At Chapel Hill |
Viral vectors with modified transduction profiles and methods of making and using the same
|
|
CN105755044A
(zh)
|
2011-04-22 |
2016-07-13 |
加利福尼亚大学董事会 |
具有变异衣壳的腺相关病毒病毒体及其使用方法
|
|
EP2559443A1
(en)
|
2011-08-16 |
2013-02-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject
|
|
ES2857773T5
(es)
|
2011-08-24 |
2024-06-04 |
Univ Leland Stanford Junior |
Nuevas proteínas de la cápside de AAV para la transferencia de ácidos nucleicos
|
|
US20130090375A1
(en)
|
2011-10-06 |
2013-04-11 |
Cornell University |
Virus-mediated delivery of bevacizumab for therapeutic applications
|
|
WO2013170078A1
(en)
|
2012-05-09 |
2013-11-14 |
Oregon Health & Science University |
Adeno associated virus plasmids and vectors
|
|
TWI698240B
(zh)
|
2012-05-15 |
2020-07-11 |
澳大利亞商艾佛蘭屈澳洲私營有限公司 |
使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd)
|
|
MX373894B
(es)
|
2012-11-08 |
2020-07-09 |
Clearside Biomedical Inc |
Métodos y dispositivos para el tratamiento de trastornos oculares en sujetos humanos.
|
|
US9567376B2
(en)
|
2013-02-08 |
2017-02-14 |
The Trustees Of The University Of Pennsylvania |
Enhanced AAV-mediated gene transfer for retinal therapies
|
|
CA2905952A1
(en)
|
2013-03-13 |
2014-10-02 |
The Children's Hospital Of Philadelphia |
Adeno-associated virus vectors and methods of use thereof
|
|
AU2014235096B2
(en)
|
2013-03-15 |
2020-03-19 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treating MPSI
|
|
ES2739288T3
(es)
|
2013-09-13 |
2020-01-30 |
California Inst Of Techn |
Recuperación selectiva
|
|
CN106232618A
(zh)
|
2013-10-11 |
2016-12-14 |
马萨诸塞眼科耳科诊所 |
预测祖先病毒序列的方法及其用途
|
|
JP6818551B2
(ja)
|
2013-12-03 |
2021-01-20 |
ホオキパ バイオテック ジーエムビーエイチ |
Ｃｍｖワクチン
|
|
GB201403684D0
(en)
|
2014-03-03 |
2014-04-16 |
King S College London |
Vector
|
|
EP3134431B1
(en)
|
2014-04-25 |
2021-04-07 |
The Trustees Of The University Of Pennsylvania |
Ldlr variants and their use in compositions for reducing cholesterol levels
|
|
WO2015164757A1
(en)
|
2014-04-25 |
2015-10-29 |
Oregon Health & Science University |
Methods of viral neutralizing antibody epitope mapping
|
|
ES2833230T3
(es)
|
2014-05-13 |
2021-06-14 |
Univ Pennsylvania |
Composiciones que comprenden AVV que expresan construcciones y usos de doble anticuerpo del mismo
|
|
EP3151866B1
(en)
|
2014-06-09 |
2023-03-08 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
US10064752B2
(en)
|
2014-09-11 |
2018-09-04 |
Orbit Biomedical Limited |
Motorized suprachoroidal injection of therapeutic agent
|
|
AU2016219789B2
(en)
|
2015-02-20 |
2021-03-25 |
Fondazione Telethon |
Methods and compositions for treating genetic eye diseases
|
|
EA201792500A1
(ru)
|
2015-05-13 |
2018-04-30 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Aav-опосредованная экспрессия антител против гриппа и способы их использования
|
|
AU2016315703A1
(en)
|
2015-08-31 |
2018-03-08 |
The Trustees Of The University Of Pennsylvania |
Chimeric AAV-anti-VEGF for treating cancer in canines
|
|
GB201519086D0
(en)
|
2015-10-28 |
2015-12-09 |
Syncona Partners Llp |
Gene Therapy
|
|
CA3010862A1
(en)
|
2016-01-08 |
2017-07-13 |
Clearside Biomedical, Inc. |
Methods and devices for treating posterior ocular disorderswith aflibercept and other biologics
|
|
KR20240005973A
(ko)
|
2016-04-15 |
2024-01-12 |
리젠엑스바이오 인크. |
완전히-인간형의 번역후 변형된 항-VEGF Fab를 이용한 눈 질환의 치료
|
|
SG11201808426XA
(en)
*
|
2016-04-15 |
2018-10-30 |
Univ Pennsylvania |
Compositions for treatment of wet age-related macular degeneration
|
|
EP3687464A4
(en)
|
2017-09-27 |
2021-09-29 |
REGENXBIO Inc. |
TREATMENT OF EYE DISEASES WITH A TOTALLY HUMAN POST-TRANSLATION MODIFIED ANTI-VEGF FAB
|
|
WO2020206098A1
(en)
|
2019-04-03 |
2020-10-08 |
Regenxbio Inc. |
Gene therapy for eye pathologies
|